
Forward
Forward was a San Francisco-based healthcare startup that shut down in November 2024.

Forward was a San Francisco-based healthcare startup that shut down in November 2024.
Demand for accessible preventive primary care remains strong, with employers and consumers seeking alternatives to appointment scarcity and rising premiums in traditional practices. Direct primary care memberships, virtual first access, and AI assisted triage continue to attract investment across the broader market.
Forward exited this market at closure, so its outlook is historical rather than forward looking. Surviving competitors continue to serve the membership based segment, while the shutdown illustrates how capital intensity and clinic cost structure constrain technology led entrants without durable funding.
Source: techcrunch.com
Forward pursued a membership model for primary care, charging consumers a flat monthly fee for unlimited visits, continuous biometric monitoring, and preventive screening without billing insurers. The thesis was that software automation plus owned clinics could deliver more thorough care at lower administrative cost than fee for service practices.
The model depended on sustained venture funding to carry clinic buildout and CarePod deployment ahead of membership scale. When capital markets tightened, the fixed cost base and nineteen location footprint left the company unable to reach self sustaining unit economics, and leadership wound the business down in November 2024.
Source: fiercehealthcare.com
Forward charged consumers a flat monthly membership of about 149 dollars for clinic based primary care, positioning the fee as a replacement for copays and insurance billing. CarePods were introduced as a lower cost self service tier at about 99 dollars per month for automated screening visits.
The bundled price covered visits, diagnostics, and ongoing monitoring without per encounter charges. That simplicity aided consumer marketing, but the fixed membership revenue had to support a physical footprint and clinical staff, which proved difficult once growth capital was no longer available.
Source: fiercehealthcare.com